Angela Yee-moon Wang MD,PhD,FRCP

Angela Yee Moon Wang, MD, PhD, FRCP, is a Clinician Scientist working at the Queen Mary Hospital, University of Hong Kong, Hong Kong and graduated from the University of New South Wales, Australia.

She is the recipient of this year's United States National Kidney Foundation Joel D. Kopple Award. She also received the John Maher Award from the International Society of Peritoneal Dialysis (ISPD) in 2006, and the Travelling Lecturer Award of the Asian and Pacific Federation of Clinical Biochemistry in 2012.

Angela is currently the President of the International Society of Renal Nutrition and Metabolism (ISRNM) and a Council member of the ISPD. She is also a North and East Asia Regional Board member of the International Society of Nephrology (ISN), Committee Member of the ISN-Advancing Clinical Trial Core Group, and Executive Committee member of the Standardized Outcomes in Nephrology (SONG) Initiative, workgroup member of the SONG-PD and SONG-HD CVD. She was an Executive Committee Member of KDIGO (Jan 2015 – Dec 2017).

She is a workgroup member of the NKF Kidney Disease Outcome Quality Initiative (KDOQI) Nutrition Guidelines in CKD (to be published in 2018/2019) and the ISPD PD Adequacy Guideline update (2017-2019). She chaired the ISPD Adult Cardiovascular and Metabolic Guidelines (2012 – 2015) and is a Subcommittee Chair of the ISPD PDOPPS. She was also a Core workgroup member of the first KDIGO – CKD-MBD guidelines (2007 – 2009).

She is a member of the Scientific Program Committee of WCN 2019 in Melbourne and co-Chairs the Renal Nutrition, Nurses and Allied Health Symposium at the WCN 2019. She also co-Chairs the upcoming ISN Frontiers Meeting 2019.

Angela serves on the editorial board of several journals: JASN, CJASN, NDT (Editor of Cardiovascular Section), Am J Nephrol, Nephron Clin Pract (Associate Editor), European Medical Journal (EMJ)-Nephrology (Editor-in-Chief), Renal Replacement Therapy (Associate Editor), Nephrology (Subject Editor), J Ren Nutr, J Diabetes, Blood Purification, Biomedicine Hub, etc. She was previously an Associate Editor of AJKD and an International Editor of CJASN.

She has given over 100 invited lectures around the world and is a key opinion leader in clinical research relating to CKD and dialysis complications, especially in the areas of cardiovascular disease, heart failure, vascular calcification, CKD-MBD, diet, and nutrition as well as residual kidney function in PD. She is the Principal Investigator of the OPERA Trial, the CASCADE study, and the PROOF Trial.